Clinical trials: Oncologic Disease
Breast Cancer, Oncologic Disorders
Horse-assisted Interventions in an Oncological Centre
This study is a non-pharmacological, controlled, randomized interventional study with two arms: standard onco-hematology therapy compared with standard therapy associated with the Equine-Assisted Therapy (EAT).
- Conditions
- Breast Cancer, Oncologic Disorders, Haematologic Disease
- Trial name
- ISACCO (NCT07831460)
- Testing
- Horse-Assisted Intervention (HAI)
- Where
- 4 sites in Italy
- Volunteers
- 28 people
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Enterobacterial Infections, Oncologic Disease
Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
In this study, the investigators will assess the hypothesis that this new positron emission tomography (PET) radiopharmaceutical, 18F-Fluorodeoxysorbitol (18F-FDS), will specifically localize at sites of Gram-negative bacterial…
- Conditions
- Enterobacterial Infections, Oncologic Disease, Inflammatory Disease, Invasive Fungal Infections
- Trial name
- NCT05611892
- Testing
- 18F-FDS PET/CT
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- Johns Hopkins University
Oncologic Diseases
Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions
To evaluate implications of biological and procedural factors of 18-f FDG PET/CT uptake on normal organs and neoplastic lesions.
- Trial name
- NCT06626932
- Testing
- 18 FDG (Fludeoxyglucose 18F)
- Where
- Egypt
- Volunteers
- 259 people
- Sponsor
- mahenoor alaa eldeen naem
Oncologic Disease, Hematologic Diseases
Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology
Currently, the molecular characterization of onco-hematological, onco-immunological and hematological diseases, at onset or in relapse, of patients with suspected diagnosis afferent to the CROP centers, is done through…
- Trial name
- NCT06304194
- Testing
- Analysis of biological samples
- Where
- 3 sites in Italy
- Volunteers
- 340 people
- Sponsor
- Meyer Children's Hospital IRCCS
Narrative Medicine, Chronic Disease
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
A qualitative study assessing the impact of early narrative medicine practice on Medical Honors Program (MHP) students' attitudes regarding patient-centered interactions, through interviewing patients with chronic or…
- Conditions
- Narrative Medicine, Chronic Disease, Terminal Illness, Cancer
- Trial name
- NCT03041571
- Testing
- Patient Provider Orientation Scale, Interview performed by MHP student
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Florida
Oncologic Disorders, Hematologic Diseases
Clinical Use of Pathogen Reduced Red Blood Cell Suspension
The aim of the study is to evaluate the effectiveness and safety of the application of pathogen inactivated RBC suspension in children with oncological and hematological diseases.
- Trial name
- NCT03426553
- Testing
- Riboflavin+UV RBC, irradiated RBC
- Where
- Russia
- Volunteers
- 50 people
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Hematologic Disorders, Oncologic Disorders
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Rituximab is frequently used in adult and pediatric cancers, blood disorders, lymphoma (a cancerous growth made up of lymphoid tissue), graft-versus-host-disease (complication that can occur after a stem cell or bone marrow…
- Conditions
- Hematologic Disorders, Oncologic Disorders, Rheumatologic Disorders
- Trial name
- NCT02484053
- Testing
- Rituximab
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Baylor College of Medicine
Nutritional and Metabolic Diseases, Oncologic Disorders
Prognostic Performance of the Naples Prognostic Score
To investigate the prognostic performance of the Naples Prognostic Score in gastric cancer patients undergoing surgery
- Trial name
- NPS (NCT03272646)
- Testing
- surgery
- Volunteers
- 477 people
- Sponsor
- University of Campania Luigi Vanvitelli